Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the expected value of the topical antifungals market over the forecast period?
The topical antifungals market size has grown strongly in recent years. It will grow from $5.64 billion in 2024 to $6.02 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increase in nosocomial infection, increase in the adoption of topical drugs, increase in number of aspergillus molds, increase in the demand for antifungal medicines, and rise in number of diabetes cases.
The topical antifungals market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising cases of poor hygiene and climate changes, rising prevalence of chronic diseases, increasing geriatric population, increasing prevalence of vulvovaginal candida, and increase in prevalence of cryptococcosis. Major trends in the forecast period include advanced drug delivery systems, shift towards more affordable, advanced diagnostic tools, artificial intelligence in drug discovery, and AI-assisted diagnosis of fungal infections.
Download Your Free Sample PDF:
What industry dynamics are acting as key growth drivers for the topical antifungals market?
The increasing prevalence of skin diseases is expected to propel the growth of the topical antifungals market going forward. Skin diseases refer to conditions that affect the skin's health, appearance, or function, such as irritation, inflammation, or infections. The rising skin diseases are largely due to increase exposure to environmental pollutants and UV radiation, which can damage skin and trigger various conditions. Topical antifungals are used for treating skin diseases as they provide targeted action against fungal pathogens, minimize systemic exposure, reduce side effects, and promote faster healing of affected areas. For instance, in April 2022, according to the American Journal of Managed Care, a US-based peer-reviewed journal, found that 43% of 40,000 patients had at least one skin condition or issue within the last 12 months. Furthermore, in March 2023, according to the World Health Organization, a Switzerland-based health organization, skin conditions are estimated to impact approximately 1.8 billion people worldwide at any given time. Therefore, the increasing prevalence of skin diseases is going to drive the topical antifungals market.
What are the fastest-growing segments in the topical antifungals market forecast period?
The topical antifungals market covered in this report is segmented –
1) By Product Type: Azoles, Allylamines, Echinocandins, Polyenes
2) By Formulation Type: Creams, Ointments, Lotions, Sprays, Powders
3) By Indication: Dermatophyte Infections, Candidiasis, Tinea Infections, Onychomycosis
4) By Distribution Channel: Pharmacies, Online Pharmacies, Hospital Pharmacies, Drug Stores
5) By End-User: Hospitals, Clinics, Home Healthcare, Pharmaceutical Companies
Subsegments:
1) By Azoles: Clotrimazole, Miconazole, Ketoconazole, Fluconazole
2) By Allylamines: Terbinafine, Naftifine, Butenafine
3) By Echinocandins: Caspofungin, Micafungin, Anidulafungin
4) By Polyenes: Nystatin, Amphotericin B
View The Full Market Report:
What are the key trends shaping the topical antifungals market in the forecast period?
Major companies operating in the topical antifungals market are focusing on developing innovative formulations such as histone deacetylase (HDAC) inhibitors to enhance therapeutic efficacy, overcome antifungal resistance, and improve nail bed penetration in the treatment of onychomycosis. HDAC inhibitors are compounds that block histone deacetylase enzymes, which remove acetyl groups from histone proteins. For instance, in January 2024, Vanda Pharmaceuticals Inc., a US-based biotech company, received U.S. Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) application to study VTR-297 as a treatment for onychomycosis, a common fungal nail infection. VTR-297 is a small molecule histone deacetylase (HDAC) inhibitor with antifungal activity. It was originally isolated from the bacterial species Streptomyces hygroscopicus and first described as an antifungal antibiotic.
Which major players hold significant market share in the topical antifungals sector?
Major companies operating in the topical antifungals market are Pfizer Inc., Bayer AG, Novartis AG, GSK plc, Fresenius Kabi AG, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd., Galderma S.A., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, LUPIN LIMITED, Zydus Cadila, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd, Taro Pharmaceutical Industries Ltd., Natco Pharma Ltd, Femcorp Pharma, Glamris Dermacare
Which regional segments are forecasted to witness the fastest growth in the topical antifungals market?
North America was the largest region in the topical antifungals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Topical Antifungals Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Topical Antifungals Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment